Anbio Biotechnology Cash Flow Statement (2023-2025) | NNNN

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Dec2023 Dec2024 Jun2025
Operating Activities
Change in Working Capital
Change in Accured Expenses 104.98B
Financing Activities
Other financing activities 387.44B
Additional items
Beginning Cash Balance 0.01B0.01B5,348.49B